FIM
NKTR icon

Freedom Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Freedom Investment Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-529
Closed -$261K – 760
2018
Q4 		$261K Sell
529
-399
-43% -$241K 0.02% 624
2018
Q3 		$954K Buy
928
+637
+219% +$544K 0.06% 334
2018
Q2 		$213K Sell
291
-312
-52% -$360K 0.01% 870
2018
Q1 		$960K Buy
603
+319
+112% +$411K 0.05% 385
2017
Q4 		$254K Buy
+284
New +$168K 0.01% 950
2016
Q1 		– Sell
-911
Closed -$230K – 871
2015
Q4 		$230K Buy
+911
New +$187K 0.02% 644

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Freedom Investment Management's NKTR Position: Q1 2019 in Review

Freedom Investment Management sold out of Nektar Therapeutics (NKTR) in Q1 2019, closing a stake of 529 shares — an estimated $261K sold.

Freedom Investment Management first reported a position in NKTR in Q4 2015 and held it in 6 quarters. The position peaked at $960K in Q1 2018. 349 funds tracked by Wall St. Rank hold NKTR as of Q1 2019.

  • Freedom Investment Management reported no remaining Nektar Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Freedom Investment Management sold 529 Nektar Therapeutics shares in Q1 2019, an estimated $261K.
  • Freedom Investment Management first reported a position in Nektar Therapeutics in Q4 2015 and held it in 6 quarters.
  • Freedom Investment Management's Nektar Therapeutics position peaked at $960K in Q1 2018.
  • 349 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2019.

Based on Freedom Investment Management's 13F filing for Q1 2019, filed 18 Apr 2019.